Itamar Medical Upsizes Nasdaq Public Offering to $35 Million
The Nasdaq and Tel Aviv-listed medical diagnosis company originally planned to raise $30 million
Tzally Greenberg | 15:04 02.02.2020
Nasdaq and Tel Aviv-listed medical diagnosis company Itamar Medical Ltd. has upsized its public offering of American Depositary Shares (ADS) on Nasdaq to $35 million, the company announced Thursday. The company originally intended to raise $30 million but increased the offering due to demand. The company’s ADSs traded on Nasdaq according to a market capitalization of $181 million on Friday close. Established in 1997 in Israeli coastal town Caesarea, Itamar Medical develops and manufactures non-invasive diagnostic devices for sleep disorders and cardiovascular diseases.